Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) and the Critical Need for Better Disease Diagnosis
Up to 70% of all medical decisions are based on lab tests. These tests cost between 3% and 6% of total patient-care costs The average patient spends about $260 on lab tests, a figure that is mainly associated with waiting for test results With point-of-care (“POC”) testing, waiting time can improve by as much as 46 minutes per patient, thus making it cheaper for the patient Avricore understands this problem, hence its investment in point-of-care technologies designed to make disease diagnosis easier, affordable, and more efficient Over the past few decades, disease diagnosis has proven to be the single most…
